相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 12-Week, Placebo-Controlled Phase 3 Trial (T3MPO-1)
William D. Chey et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Deciphering ion transporters, kinases and PDZ-adaptor molecules that mediate guanylate cyclase C agonist-dependent intestinal fluid loss in vivo
Yongjian Liu et al.
BIOCHEMICAL PHARMACOLOGY (2020)
ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020
Elliott Lilley et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
Nathalie Percie du Sert et al.
PLOS BIOLOGY (2020)
Distal intestinal obstructive syndrome (DIOS): a gastrointestinal complication of cystic fibrosis in adults
Marianna Mavilia
CLINICAL JOURNAL OF GASTROENTEROLOGY (2019)
Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers
Michael J. Curtis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Pharmacodynamics, Safety, and Tolerability of the NHE3 Inhibitor Tenapanor: Two Trials in Healthy Volunteers
David P. Rosenbaum et al.
CLINICAL DRUG INVESTIGATION (2018)
Cystic fibrosis transmembrane conductance regulator modulators: precision medicine in cystic fibrosis
Elizabeth B. Burgener et al.
CURRENT OPINION IN PEDIATRICS (2018)
Linaclotide improves gastrointestinal transit in cystic fibrosis mice by inhibiting sodium/hydrogen exchanger 3
Daniel R. McHugh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2018)
Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis
Christopher J. Black et al.
GASTROENTEROLOGY (2018)
Cftr Modulates Wnt/β-Catenin Signaling and Stem Cell Proliferation in Murine Intestine
Ashlee M. Strubberg et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2018)
Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis
Jessica Green et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)
Cystic Fibrosis & disorders of the large intestine: DIOS, constipation, and colorectal cancer
James M. Abraham et al.
Journal of Cystic Fibrosis (2017)
Bacterial overgrowth, dysbiosis, inflammation, and dysmotility in the Cystic Fibrosis intestine
Jill Dorsey et al.
Journal of Cystic Fibrosis (2017)
Bypassing CFTR dysfunction in cystic fibrosis with alternative pathways for anion transport
Hongyu Li et al.
CURRENT OPINION IN PHARMACOLOGY (2017)
Tenapanor administration and the activity of the H+-coupled transporter PepT1 in healthy volunteers
Susanne Johansson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention
David S. Weinberg et al.
CANCER PREVENTION RESEARCH (2017)
Linaclotide activates guanylate cyclase-C/cGMP/protein kinase-II-dependent trafficking of CFTR in the intestine
Md. Kaimul Ahsan et al.
PHYSIOLOGICAL REPORTS (2017)
Guanylin and uroguanylin are produced by mouse intestinal epithelial cells of columnar and secretory lineage
Pauline T. Ikpa et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2016)
Defective goblet cell exocytosis contributes to murine cystic fibrosis-associated intestinal disease
Jinghua Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
ClC-2 regulation of intestinal barrier function: Translation of basic science to therapeutic target
Younggeon Jin et al.
TISSUE BARRIERS (2015)
Differentiation between human ClC-2 and CFTR Cl- channels with pharmacological agents
John Cuppoletti et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2014)
The multiple roles of guanylate cyclase C, a heat stable enterotoxin receptor
Kris A. Steinbrecher
CURRENT OPINION IN GASTROENTEROLOGY (2014)
Cystic fibrosis: Evidence for gut inflammation
Anne Munck
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Effects of Lubiprostone on Pacemaker Activity of Interstitial Cells of Cajal from the Mouse Colon
Han-Yi Jiao et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2014)
Microbial-induced meprin β cleavage in MUC2 mucin and a functional CFTR channel are required to release anchored small intestinal mucus
Andre Schutte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Intestinal Inhibition of the Na+/H+ Exchanger 3 Prevents Cardiorenal Damage in Rats and Inhibits Na+ Uptake in Humans
Andrew G. Spencer et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Lubiprostone Decreases Mouse Colonic Inner Mucus Layer Thickness and Alters Intestinal Microbiota
Mark W. Musch et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
Increased Epithelial Permeability Is the Primary Cause for Bicarbonate Loss in Inflamed Murine Colon
Marina Juric et al.
INFLAMMATORY BOWEL DISEASES (2013)
Normal mucus formation requires cAMP-dependent HCO3- secretion and Ca2+-mediated mucin exocytosis
Ning Yang et al.
JOURNAL OF PHYSIOLOGY-LONDON (2013)
The Cystic Fibrosis Intestine
Robert C. De Lisle et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
Lubiprostone Increases Small Intestinal Smooth Muscle Contractions Through a Prostaglandin E Receptor 1 (EP1)-mediated Pathway
Walter W. Chan et al.
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2013)
Lubiprostone stimulates small intestinal mucin release
Robert C. De Lisle
BMC GASTROENTEROLOGY (2012)
Lubiprostone Targets Prostanoid Signaling and Promotes Ion Transporter Trafficking, Mucus Exocytosis, and Contractility
Robert L. Jakab et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
May the Truth Be with You: Lubiprostone as EP Receptor Agonist/ClC-2 Internalizing Inhibitor
Yasutada Akiba et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
Loss of downregulated in adenoma (DRA) impairs mucosal HCO3-secretion in murine ileocolonic inflammation
Fang Xiao et al.
INFLAMMATORY BOWEL DISEASES (2012)
Rescue of epithelial HCO3- secretion in murine intestine by apical membrane expression of the cystic fibrosis transmembrane conductance regulator mutant F508del
Fang Xiao et al.
JOURNAL OF PHYSIOLOGY-LONDON (2012)
Lubiprostone for Constipation in Adults with Cystic Fibrosis: A Pilot Study
Catherine E. O'Brien et al.
ANNALS OF PHARMACOTHERAPY (2011)
Mouse models of cystic fibrosis: Phenotypic analysis and research applications
Martina Wilke et al.
JOURNAL OF CYSTIC FIBROSIS (2011)
Lubiprostone ameliorates the cystic fibrosis mouse intestinal phenotype
Robert C. De Lisle et al.
BMC GASTROENTEROLOGY (2010)
Defining DIOS and Constipation in Cystic Fibrosis With a Multicentre Study on the Incidence, Characteristics, and Treatment of DIOS
Roderick H. Houwen et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2010)
Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract
Alexander P. Bryant et al.
LIFE SCIENCES (2010)
Reduced NHE3-mediated Na+ absorption increases survival and decreases the incidence of intestinal obstructions in cystic fibrosis mice
Emily M. Bradford et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
Lubiprostone Stimulates Duodenal Bicarbonate Secretion in Rats
Misa Mizumori et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Activation of Intestinal Cl- Secretion by Lubiprostone Requires the Cystic Fibrosis Transmembrane Conductance Regulator
Marcel J. C. Bijvelds et al.
GASTROENTEROLOGY (2009)
Activation of prostaglandin EP receptors by lubiprostone in rat and human stomach and colon
A. K. Bassil et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Effects of laxative and N-acetylcysteine on mucus accumulation, bacterial load, transit, and inflammation in the cystic fibrosis mouse small intestine
Robert C. De Lisle et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
H+-coupled nutrient, micronutrient and drug transporters in the mammalian small intestine
David T. Thwaites et al.
EXPERIMENTAL PHYSIOLOGY (2007)
Lubiprostone: A chloride channel activator for treatment of chronic constipation
Emily M. Ambizas et al.
ANNALS OF PHARMACOTHERAPY (2007)
G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences
Franz Faul et al.
BEHAVIOR RESEARCH METHODS (2007)
cGMP inhibition of Na+/H+ antiporter 3 (NHE3) requires PDZ domain adapter NHERF2, a broad specificity protein kinase G-anchoring protein
B Cha et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Electroneutral sodium absorption and electrogenic anion secretion across murine small intestine are regulated in parallel
LR Gawenis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)
Inhibition of neutral sodium absorption by a prostaglandin analogue in patients with cystic fibrosis
SW Coates et al.
GASTROENTEROLOGY (2004)
cAMP inhibition of murine intestinal Na+/H+ exchange requires CFTR-mediated cell shrinkage of villus epithelium
LR Gawenis et al.
GASTROENTEROLOGY (2003)
Effect of vasoactive intestinal polypeptide (VIP) antagonism on rat jejunal fluid and electrolyte secretion induced by cholera and Escherichia coli enterotoxins
FH Mourad et al.
GUT (2000)
分享论文
